Pricing Log in Create free account

Enlivex Ltd. (ENLV) vs Lunai Bioworks Inc. (LNAI)

Enlivex Ltd. and Lunai Bioworks Inc. are both Biotechnology companies. Enlivex Ltd. and Lunai Bioworks Inc. are of similar size ($4.5M and $4.2M). Lunai Bioworks Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Enlivex Ltd. has the higher net margin (0.00% vs −3,761.9%) and the lower return on invested capital (−5.85% vs 0.00%). Across the 13 metrics below, Enlivex Ltd. leads on 9 and Lunai Bioworks Inc. on 4.

Valuation

Metric ENLV LNAI Biotechnology median
P/E 0.00 n/m 8.50
P/S n/m 24.13 9.71
P/B 0.00 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 240.66 n/m 0.64
EV/Sales n/m 18.71 9.21
Earnings yield 248,526.43% (150.78%) (33.15%)
Free cash flow yield (301.79%) (232.47%) (25.50%)

Profitability

Metric ENLV LNAI Biotechnology median
Gross margin 0.00% (3.48%) 65.16%
Operating margin 0.00% (9,184.79%) 0.00%
Net margin 0.00% (3,761.88%) 0.00%
Free cash flow margin 0.00% (5,610.24%) 0.00%
Return on equity 159.77% 23.46% (56.36%)
Return on assets 127.16% (39.21%) (48.04%)
Return on invested capital (5.85%) 0.00% 0.00%

Growth

Metric ENLV LNAI Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 3,590.26% 98.77% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 119.39 0.11 4.72
Net debt to EBITDA 118.29 0.20 0.96

Dividend

Metric ENLV LNAI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENLV LNAI Biotechnology median
Market cap 4.46m 4.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack